Cytokinetics, Incorporated
NASDAQ:CYTK
46.87 (USD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 7.53 | 94.588 | 70.428 | 55.828 | 26.868 | 31.501 | 13.368 | 106.407 | 28.658 | 46.94 | 30.648 | 7.559 | 4 | 2.577 | 81.538 | 12.42 | 13.622 | 3.127 | 8.912 | 13.442 | 10.577 | 11.396 | 8.466 | 0 |
| Cost of Revenue
| 330.123 | 240.813 | 159.938 | 96.951 | 86.125 | 89.135 | 90.296 | 59.897 | 46.398 | 44.426 | 49.45 | 35 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -322.593 | -146.225 | -89.51 | -41.123 | -59.257 | -57.634 | -76.928 | 46.51 | -17.74 | 2.514 | -18.802 | -27.441 | 4 | 2.577 | 81.538 | 12.42 | 13.622 | 3.127 | 8.912 | 13.442 | 10.577 | 11.396 | 8.466 | 0 |
| Gross Profit Ratio
| -42.841 | -1.546 | -1.271 | -0.737 | -2.205 | -1.83 | -5.755 | 0.437 | -0.619 | 0.054 | -0.613 | -3.63 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Reseach & Development Expenses
| 0 | 6.588 | 159.938 | 96.951 | 86.125 | 89.135 | 90.296 | 59.897 | 46.398 | 44.426 | 49.45 | 35 | 37.182 | 38.013 | 39.84 | 53.95 | 53.388 | 49.225 | 40.57 | 39.885 | 34.004 | 28.424 | 20.961 | 10.403 |
| General & Administrative Expenses
| 173.612 | 177.977 | 96.803 | 52.82 | 39.61 | 31.282 | 36.468 | 27.823 | 19.667 | 17.268 | 15.092 | 11.717 | 13.59 | 14.199 | 15.626 | 15.076 | 16.721 | 15.24 | 12.975 | 11.991 | 9.163 | 6.953 | 5.897 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 173.612 | 177.977 | 96.803 | 52.82 | 39.61 | 31.282 | 36.468 | 27.823 | 19.667 | 17.268 | 15.092 | 11.717 | 13.59 | 14.199 | 15.626 | 15.076 | 16.721 | 15.24 | 12.975 | 11.991 | 9.163 | 6.953 | 5.897 | 3.39 |
| Other Expenses
| 0 | -6.588 | -159.938 | -96.951 | -86.125 | 0 | 0 | 58.655 | 31.733 | 24.888 | 47.431 | 31.41 | 36.32 | 36.526 | 32.646 | 56.237 | 52 | 47.603 | 35.592 | 30.547 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 173.612 | 177.977 | 96.803 | 52.82 | 39.61 | 31.282 | 36.468 | 27.823 | 19.667 | 17.268 | 15.092 | 11.717 | 50.772 | 52.212 | 55.466 | 69.026 | 70.109 | 64.465 | 53.545 | 51.876 | 43.167 | 35.377 | 26.858 | 13.793 |
| Operating Income
| -496.205 | -324.202 | -186.313 | -93.943 | -98.867 | -88.916 | -113.396 | 18.687 | -37.407 | -14.754 | -33.894 | -39.102 | -47.964 | -49.635 | 26.095 | -59.079 | -56.487 | -61.338 | -44.633 | -38.434 | -32.59 | -23.981 | -18.392 | -13.793 |
| Operating Income Ratio
| -65.897 | -3.428 | -2.645 | -1.683 | -3.68 | -2.823 | -8.483 | 0.176 | -1.305 | -0.314 | -1.106 | -5.173 | -11.991 | -19.261 | 0.32 | -4.757 | -4.147 | -19.616 | -5.008 | -2.859 | -3.081 | -2.104 | -2.172 | 0 |
| Total Other Income Expenses Net
| -30.039 | -64.753 | -29.001 | -33.347 | -22.825 | -17.373 | -14.394 | -2.234 | -0.094 | 0.108 | 0.177 | 0.087 | 0.104 | 0.172 | -1.401 | 0.232 | 7.593 | 4.223 | 2.381 | 1.236 | 0 | 0 | 18.392 | 0 |
| Income Before Tax
| -526.244 | -388.955 | -215.314 | -127.29 | -121.692 | -106.289 | -127.79 | 16.453 | -37.501 | -14.646 | -33.717 | -39.015 | -47.86 | -49.463 | 24.694 | -56.374 | -48.894 | -57.115 | -42.252 | -37.198 | 0 | 0 | 0 | 0 |
| Income Before Tax Ratio
| -69.886 | -4.112 | -3.057 | -2.28 | -4.529 | -3.374 | -9.559 | 0.155 | -1.309 | -0.312 | -1.1 | -5.161 | -11.965 | -19.194 | 0.303 | -4.539 | -3.589 | -18.265 | -4.741 | -2.767 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 13.597 | 27.056 | 36.845 | 27.36 | 4.191 | 0.682 | -0.741 | -0.589 | -0.49 | -0.433 | -0.678 | -0.209 | -0.176 | 0.15 | -0.232 | 0 | 0 | 0 | 0 | 0.095 | -0.901 | 15.874 | 13.079 |
| Net Income
| -526.244 | -402.552 | -242.37 | -164.135 | -149.052 | -106.289 | -127.79 | 16.453 | -37.501 | -14.646 | -33.717 | -39.015 | -47.86 | -49.287 | 24.544 | -56.374 | -48.894 | -57.115 | -42.252 | -37.198 | -32.685 | -23.08 | -15.874 | -13.079 |
| Net Income Ratio
| -69.886 | -4.256 | -3.441 | -2.94 | -5.548 | -3.374 | -9.559 | 0.155 | -1.309 | -0.312 | -1.1 | -5.161 | -11.965 | -19.126 | 0.301 | -4.539 | -3.589 | -18.265 | -4.741 | -2.767 | -3.09 | -2.025 | -1.875 | 0 |
| EPS
| -5.45 | -4.48 | -3.15 | -2.54 | -2.59 | -1.95 | -2.59 | 0.41 | -0.97 | -0.41 | -1.24 | -2.15 | -4.06 | -4.61 | 2.58 | -6.85 | -6.16 | -9.36 | -8.87 | -11.28 | -102.62 | -79.49 | -67.08 | -81.3 |
| EPS Diluted
| -5.45 | -4.48 | -3.15 | -2.54 | -2.59 | -1.95 | -2.59 | 0.39 | -0.97 | -0.41 | -1.24 | -2.15 | -4.06 | -4.61 | 2.52 | -6.85 | -6.16 | -9.36 | -8.87 | -11.28 | -102.6 | -79.49 | -67.08 | -81.3 |
| EBITDA
| -456.684 | -329.4 | -176.345 | -86.783 | -93.039 | -83.486 | -108.894 | 14.928 | -36.662 | -14.156 | -33.284 | -39.777 | -46.524 | -47.4 | 27.124 | -53.427 | -45.366 | -53.657 | -38.681 | -33.387 | -29.409 | -21.132 | -18.392 | -13.793 |
| EBITDA Ratio
| -60.649 | -3.308 | -2.641 | -1.587 | -3.463 | -2.69 | -8.288 | 0.176 | -1.305 | -0.314 | -1.106 | -5.18 | -11.395 | -19.261 | 0.319 | -4.161 | -3.939 | -18.68 | -4.665 | -2.616 | -2.78 | -1.854 | -2.172 | 0 |